Search results
Merck's (NYSE:MRK) investors will be pleased with their notable 90% return over the last three years
Simply Wall St. via Yahoo Finance· 16 hours agoBy buying an index fund, investors can approximate the average market return. But if you pick the...
Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know
Zacks via Yahoo Finance· 2 days agoMerck (MRK) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good...
Merck's endometrial cancer therapy fails trial
Reuters via Yahoo News· 2 days agoThe drugmaker's Keytruda therapy in combination with chemotherapy was being evaluated in about 1,095 patients with high-risk endometrial cancer after...
Merck Expands Access to High-Quality Maternal Care for More Than 30 Million Women Worldwide Through ...
Morningstar· 3 days agoRAHWAY, NJ / ACCESSWIRE / May 8, 2024 / Merck (NYSE:MRK), known as MSD outside of the United States and Canada, announced today that Merck for Mothers, ...
Merck’s trial of KEYTRUDA regimen fails to meet primary endpoint
Clinical Trials Arena via Yahoo Finance· 18 hours agoMerck has announced that its Phase III KEYNOTE-B21 (ENGOT-en11/GOG-3053) clinical trial of KEYTRUDA...
Dow Jones Drug Giant Merck, Nvidia Eye Buy Points In Current Stock Market
Investor's Business Daily· 4 days agoAmong the best stocks to watch, Dow Jones drug giant Merck, Nvidia, Chipotle Mexican Grill and NXP...
Dow Jones Cuts Gains After Hot Inflation Data; Nvidia Rallies On Strong TSMC Sales
Investor's Business Daily· 13 hours agoChipotle and Merck featured in this Stocks Near A Buy Zone column. An essential resource for daily...
Merck and other pharma giants are bracing for competition to their blockbuster drugs. Here's how.
Quartz· 3 days agoEvery pharmaceutical company is constantly searching for its next blockbuster — the billion-dollar...
Merck Study of Keytruda With Chemotherapy in Endometrial Cancer Fails to Meet Endpoint
Morningstar· 2 days agoMerck was hit with a setback in its efforts to expand its blockbuster cancer immunotherapy Keytruda after a late-stage study of its use in combination with chemotherapy to ...
Merck treatment for a type of uterus cancer fails trial
WHTC 1450 Holland· 2 days ago(Reuters) - Merck said on Thursday its treatment for a type of uterus cancer did not meet the main...